Collecting spinal fluid samples to help Huntington’s research
Part of Brain & nervous system, Genetic & congenital, Mental health clinical trials.
This study gathers small samples of spinal fluid from people affected by Huntington’s disease. Researchers use these samples to better understand the disease and support future treatments. If you join, you’ll need to follow their sample and visit schedule.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 (or meet the juvenile Huntington’s age range).
- You have Huntington’s disease (including early “premanifest” or “manifest” forms).
- If you’re not a family/community control, you must have had genetic testing confirming Huntington’s disease.
- You must be able to consent or have a legal representative, and you must be able to follow study visits.
- You must be willing to have a needle placed for spinal fluid (lumbar puncture) if needed.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This first-in-human study tests whether SRP-1005, a new drug, is safe and tolerable in people with early Huntington's disease. The drug is designed to reduce levels of a harmful protein in the brain that causes Huntington's symptoms.
This trial tests a new radioactive tracer called [11C]CHDI-00491009 that may show mutant huntingtin protein in the brain using a PET scan. It aims to find out if the tracer is safe and helps see Huntington's disease changes. If you have early-stage Huntington's or are a healthy volunteer, you may be able to join.
This is an early-phase study testing a new drug (RG6496) for people with Huntington's disease. The study will check the drug's safety and how the body processes it, and it requires two doses given about 6 months apart.
This study builds a global record of people who carry the Huntington’s (HD) gene change and people who do not. By comparing them over time, researchers hope to better understand how HD begins and progresses.
This trial tests a new drug called SKY-0515 in people with Huntington's disease. The goal is to see if it can safely improve symptoms or slow the disease down.
This study is collecting tiny particles called extracellular vesicles from blood and spinal fluid to learn more about Huntington's disease. It aims to find better ways to measure the disease in people who have HD and in those who do not.
Hear when a new Huntington's Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.